JP2014524888A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524888A5
JP2014524888A5 JP2014511830A JP2014511830A JP2014524888A5 JP 2014524888 A5 JP2014524888 A5 JP 2014524888A5 JP 2014511830 A JP2014511830 A JP 2014511830A JP 2014511830 A JP2014511830 A JP 2014511830A JP 2014524888 A5 JP2014524888 A5 JP 2014524888A5
Authority
JP
Japan
Prior art keywords
phenyl
alkyl
substituted
precatalyst
disproportionated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524888A (ja
JP5925301B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/059344 external-priority patent/WO2012160015A1/en
Publication of JP2014524888A publication Critical patent/JP2014524888A/ja
Publication of JP2014524888A5 publication Critical patent/JP2014524888A5/ja
Application granted granted Critical
Publication of JP5925301B2 publication Critical patent/JP5925301B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014511830A 2011-05-23 2012-05-21 N−アルキル基を含有するジュウテリウム化化合物の製造方法 Expired - Fee Related JP5925301B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11305634 2011-05-23
EP11305634.5 2011-05-23
PCT/EP2012/059344 WO2012160015A1 (en) 2011-05-23 2012-05-21 Process for the preparation of deuterated compounds containing n-alkyl groups

Publications (3)

Publication Number Publication Date
JP2014524888A JP2014524888A (ja) 2014-09-25
JP2014524888A5 true JP2014524888A5 (enExample) 2015-07-02
JP5925301B2 JP5925301B2 (ja) 2016-05-25

Family

ID=46146876

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511830A Expired - Fee Related JP5925301B2 (ja) 2011-05-23 2012-05-21 N−アルキル基を含有するジュウテリウム化化合物の製造方法

Country Status (10)

Country Link
US (1) US9340489B2 (enExample)
EP (1) EP2714624B1 (enExample)
JP (1) JP5925301B2 (enExample)
KR (1) KR20140030267A (enExample)
CN (1) CN103702961A (enExample)
CA (1) CA2834920A1 (enExample)
IL (1) IL229037A0 (enExample)
RU (1) RU2013156864A (enExample)
SG (1) SG194625A1 (enExample)
WO (1) WO2012160015A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3152200A1 (en) 2014-06-06 2017-04-12 Research Triangle Institute Apelin receptor (apj) agonists and uses thereof
MX377327B (es) * 2014-11-10 2025-03-07 Forge Life Science Llc Metodo y composiciones de anti-hcmv.
US10100059B2 (en) 2015-12-09 2018-10-16 Research Triangle Institute Apelin receptor (APJ) agonists and uses thereof
WO2018053222A1 (en) 2016-09-16 2018-03-22 Research Traingle Institute Tetrahydroisoquinoline kappa opioid antagonists
EP3526209B1 (en) 2016-10-12 2025-04-16 Research Triangle Institute Heterocyclic apelin receptor (apj) agonists and uses thereof
JOP20190072A1 (ar) 2016-10-13 2019-04-07 Glaxosmithkline Ip Dev Ltd مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم
AU2017382217B2 (en) 2016-12-21 2021-07-08 Research Triangle Institute Diaryl purine derivatives with improved bioavailability
WO2018200882A1 (en) * 2017-04-27 2018-11-01 Deuteria Beverages, Llc Process for the preparation of deuterated ethanol from d2
EA039504B1 (ru) * 2017-04-27 2022-02-03 Дьютерия Бевериджес, Ллс Способ получения дейтерированного этанола из d2o
CA3072362A1 (en) 2017-10-06 2019-04-11 Forma Therapeutics, Inc. Inhibiting ubiquitin specific peptidase 30
CN109748767A (zh) * 2017-11-07 2019-05-14 朱允涛 一种利用微波反应装置制备氘代胺类化合物的方法
SG11202011299PA (en) 2018-05-17 2020-12-30 Forma Therapeutics Inc Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors
EP3840745A4 (en) 2018-08-20 2022-06-08 Duke University METHODS AND COMPOSITIONS FOR MEDICINES FOR TREATING OPHTHALMIC DISEASES
MY209034A (en) 2018-10-05 2025-06-17 Forma Therapeutics Inc Fused pyrrolines which act as ubiquitin-specific protease 30 (usp30) inhibitors
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
CN113747870B (zh) * 2018-12-21 2025-08-01 泰兰生物科技有限公司 氟利色林的氘化形式和衍生物
US12441707B2 (en) 2019-12-30 2025-10-14 Tyra Biosciences, Inc. Indazole compounds
PE20240687A1 (es) 2020-12-30 2024-04-10 Tyra Biosciences Inc Compuestos de indazol como inhibidores de cinasas

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US5167948A (en) * 1987-08-07 1992-12-01 Mallinckrodt Medical, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
EP0531410B1 (en) 1990-06-01 1994-11-30 Merrell Dow Pharmaceuticals Inc. (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinemethanol
AU707748B2 (en) * 1994-03-25 1999-07-22 Isotechnika Inc. Enhancement of the efficacy of drugs by deuteration
JP4497815B2 (ja) 2001-02-16 2010-07-07 アベンティス・ファーマスーティカルズ・インコーポレイテツド 新規な複素環式アミド誘導体およびドーパミンd3受容体リガンドとしてのその使用
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
TW200413274A (en) * 2002-12-27 2004-08-01 Wako Pure Chem Ind Ltd Deuteration or tritiation method
EP1707548A4 (en) 2004-01-23 2007-08-15 Wako Pure Chem Ind Ltd DEUTERIZATION PROCEDURE USING A MIXED CATALYST
US20080261926A1 (en) * 2007-04-02 2008-10-23 Liu Julie F Pharmaceutical Calcimimetics
WO2009005069A1 (ja) * 2007-07-05 2009-01-08 Wako Pure Chemical Industries, Ltd. ルテニウム触媒を用いた重水素化方法
US20100143287A1 (en) * 2008-12-09 2010-06-10 Auspex Pharmaceuticals, Inc. Trifluoromethylphenyl modulators of calcium-sensing receptor

Similar Documents

Publication Publication Date Title
JP2014524888A5 (enExample)
JP2013040159A5 (ja) 有機金属錯体
JP2013147496A5 (ja) 有機金属錯体
JP2014029971A5 (ja) 有機化合物
JP2013102146A5 (ja) 化合物
JP2013010749A5 (ja) カルバゾール化合物
JP2015042636A5 (ja) 有機化合物
JP2012140458A5 (enExample)
JP2013010752A5 (ja) 有機金属錯体
JP2012149030A5 (ja) 化合物
JP2013126982A5 (ja) 有機金属錯体及び発光材料
JP2012248871A5 (ja) 発光素子および発光装置
JP2012092103A5 (enExample)
JP2014158032A5 (enExample)
JP2010241801A5 (enExample)
JP2012006912A5 (ja) トリアゾール誘導体
JP2015522045A5 (enExample)
JP2013100341A5 (enExample)
JP2011121940A5 (ja) 発光素子
JP2009535462A5 (enExample)
JP2010189376A5 (ja) 有機金属錯体
JP2013010096A5 (enExample)
JP2015078176A5 (enExample)
JP2012140436A5 (ja) 物質
JP2012107003A5 (ja) 有機金属錯体